Literature DB >> 31659314

Teamwork by different T-cell types boosts tumour destruction by immunotherapy.

Jonathan L Linehan, Lélia Delamarre.   

Abstract

Entities:  

Keywords:  Cancer; Immunology

Mesh：

Substances：

Year:  2019        PMID： 31659314     DOI： 10.1038/d41586-019-03106-1

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  9 in total

Review 1.  CD4+ T cell help in cancer immunology and immunotherapy.

Authors:  Jannie Borst; Tomasz Ahrends; Nikolina Bąbała; Cornelis J M Melief; Wolfgang Kastenmüller
Journal:  Nat Rev Immunol       Date:  2018-10       Impact factor: 53.106

2.  Primary antitumor immune response mediated by CD4+ T cells.

Authors:  Alexandre Corthay; Dag K Skovseth; Katrin U Lundin; Egil Røsjø; Hilde Omholt; Peter O Hofgaard; Guttorm Haraldsen; Bjarne Bogen
Journal:  Immunity       Date:  2005-03       Impact factor: 31.745

3.  Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer.

Authors:  Eric Tran; Simon Turcotte; Alena Gros; Paul F Robbins; Yong-Chen Lu; Mark E Dudley; John R Wunderlich; Robert P Somerville; Katherine Hogan; Christian S Hinrichs; Maria R Parkhurst; James C Yang; Steven A Rosenberg
Journal:  Science       Date:  2014-05-09       Impact factor: 47.728

4.  Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction.

Authors:  Jennifer G Abelin; Dewi Harjanto; Matthew Malloy; Prerna Suri; Tyler Colson; Scott P Goulding; Amanda L Creech; Lia R Serrano; Gibran Nasir; Yusuf Nasrullah; Christopher D McGann; Diana Velez; Ying S Ting; Asaf Poran; Daniel A Rothenberg; Sagar Chhangawala; Alex Rubinsteyn; Jeff Hammerbacher; Richard B Gaynor; Edward F Fritsch; Joel Greshock; Rob C Oslund; Dominik Barthelme; Terri A Addona; Christina M Arieta; Michael S Rooney
Journal:  Immunity       Date:  2019-09-05       Impact factor: 31.745

5.  High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy.

Authors:  Matthew M Gubin; Ekaterina Esaulova; Jeffrey P Ward; Olga N Malkova; Daniele Runci; Pamela Wong; Takuro Noguchi; Cora D Arthur; Wei Meng; Elise Alspach; Ruan F V Medrano; Catrina Fronick; Michael Fehlings; Evan W Newell; Robert S Fulton; Kathleen C F Sheehan; Stephen T Oh; Robert D Schreiber; Maxim N Artyomov
Journal:  Cell       Date:  2018-10-18       Impact factor: 41.582

6.  An immunogenic personal neoantigen vaccine for patients with melanoma.

Authors:  Patrick A Ott; Zhuting Hu; Derin B Keskin; Sachet A Shukla; Jing Sun; David J Bozym; Wandi Zhang; Adrienne Luoma; Anita Giobbie-Hurder; Lauren Peter; Christina Chen; Oriol Olive; Todd A Carter; Shuqiang Li; David J Lieb; Thomas Eisenhaure; Evisa Gjini; Jonathan Stevens; William J Lane; Indu Javeri; Kaliappanadar Nellaiappan; Andres M Salazar; Heather Daley; Michael Seaman; Elizabeth I Buchbinder; Charles H Yoon; Maegan Harden; Niall Lennon; Stacey Gabriel; Scott J Rodig; Dan H Barouch; Jon C Aster; Gad Getz; Kai Wucherpfennig; Donna Neuberg; Jerome Ritz; Eric S Lander; Edward F Fritsch; Nir Hacohen; Catherine J Wu
Journal:  Nature       Date:  2017-07-05       Impact factor: 49.962

7.  Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12.

Authors:  Christopher S Garris; Sean P Arlauckas; Rainer H Kohler; Marcel P Trefny; Seth Garren; Cécile Piot; Camilla Engblom; Christina Pfirschke; Marie Siwicki; Jeremy Gungabeesoon; Gordon J Freeman; Sarah E Warren; SuFey Ong; Erica Browning; Christopher G Twitty; Robert H Pierce; Mai H Le; Alain P Algazi; Adil I Daud; Sara I Pai; Alfred Zippelius; Ralph Weissleder; Mikael J Pittet
Journal:  Immunity       Date:  2018-12-11       Impact factor: 43.474

8.  Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens.

Authors:  Matthew M Gubin; Xiuli Zhang; Heiko Schuster; Etienne Caron; Jeffrey P Ward; Takuro Noguchi; Yulia Ivanova; Jasreet Hundal; Cora D Arthur; Willem-Jan Krebber; Gwenn E Mulder; Mireille Toebes; Matthew D Vesely; Samuel S K Lam; Alan J Korman; James P Allison; Gordon J Freeman; Arlene H Sharpe; Erika L Pearce; Ton N Schumacher; Ruedi Aebersold; Hans-Georg Rammensee; Cornelis J M Melief; Elaine R Mardis; William E Gillanders; Maxim N Artyomov; Robert D Schreiber
Journal:  Nature       Date:  2014-11-27       Impact factor: 49.962

Review 9.  Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion.

Authors:  Flávia Castro; Ana Patrícia Cardoso; Raquel Madeira Gonçalves; Karine Serre; Maria José Oliveira
Journal:  Front Immunol       Date:  2018-05-04       Impact factor: 7.561
  9 in total
  1 in total

1.  Joint effort needed.

Authors:  Lucy Bird
Journal:  Nat Rev Immunol       Date:  2019-12       Impact factor: 53.106
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.